Organic compounds -- part of the class 532-570 series – Organic compounds – Oxygen containing
Patent
1995-06-02
1997-12-09
Shaver, Paul F.
Organic compounds -- part of the class 532-570 series
Organic compounds
Oxygen containing
568624, C07C 4302, C07C 4304, C07C 4311
Patent
active
056962983
ABSTRACT:
The present invention comprises novel preparations of polyoxypropylene/polyoxyethylene copolymers which retain the therapeutic activity of the commercial preparations, but are substantially free from the undesirable effects which are inherent in the prior art preparations. Because the preparations of polyoxypropylene/polyoxyethylene copolymers which comprise the present invention are a less polydisperse population of molecules than the prior art polyoxypropylene/polyoxyethylene copolymers, the biological activity of the copolymers is better defined and more predictable.
REFERENCES:
patent: Re29909 (1979-02-01), Kurtz
patent: 2674619 (1954-04-01), Lundsted
patent: 2854378 (1958-09-01), Buckwalter et al.
patent: 2979528 (1961-04-01), Lundsted
patent: 3036118 (1962-05-01), Jackson
patent: 3089818 (1963-05-01), Stone
patent: 3140232 (1964-07-01), Noseworthy
patent: 3228834 (1966-01-01), Gans
patent: 3391196 (1968-07-01), Earing et al.
patent: 3450502 (1969-06-01), Hymes
patent: 3577522 (1971-05-01), Hymes
patent: 3590125 (1971-06-01), Hymes
patent: 3641240 (1972-02-01), Hymes et al.
patent: 3740421 (1973-06-01), Schmolka
patent: 3867521 (1975-02-01), Miskel et al.
patent: 3867533 (1975-02-01), Schmolka
patent: 3956259 (1976-05-01), Garcia et al.
patent: 3980772 (1976-09-01), Ginger et al.
patent: 4073886 (1978-02-01), Kehm
patent: 4100271 (1978-07-01), Krezanoski
patent: 4104455 (1978-08-01), Nagasawa et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4186253 (1980-01-01), Yokoyama et al.
patent: 4305922 (1981-12-01), Rhodes
patent: 4378347 (1983-03-01), Franco
patent: 4395393 (1983-07-01), Schmolka
patent: 4407790 (1983-10-01), Oakes et al.
patent: 4600652 (1986-07-01), Solomon et al.
patent: 4606918 (1986-08-01), Allison et al.
patent: 4609546 (1986-09-01), Hiratani
patent: 4801452 (1989-01-01), Hunter et al.
patent: 4837014 (1989-06-01), Hunter et al.
patent: 4837083 (1989-06-01), Hunter et al.
patent: 4879109 (1989-11-01), Hunter
patent: 4897263 (1990-01-01), Hunter
patent: 4937070 (1990-06-01), Hunter
patent: 4997644 (1991-03-01), Hunter
patent: 5017370 (1991-05-01), Hunter et al.
patent: 5028599 (1991-07-01), Hunter
patent: 5030448 (1991-07-01), Hunter
patent: 5032394 (1991-07-01), Hunter
patent: 5039520 (1991-08-01), Hunter
patent: 5041288 (1991-08-01), Hunter
patent: 5047236 (1991-09-01), Hunter et al.
patent: 5064643 (1991-11-01), Hunter et al.
patent: 5071649 (1991-12-01), Hunter
patent: 5078995 (1992-01-01), Hunter et al.
patent: 5080894 (1992-01-01), Hunter et al.
patent: 5089260 (1992-02-01), Hunter et al.
patent: 5250294 (1993-10-01), Hunter et al.
patent: 5294365 (1994-03-01), Welch et al.
patent: 5340916 (1994-08-01), Henn et al.
patent: 5371253 (1994-12-01), Cooper
Advances in Blood Substitute Research (ed. by Bolin, et al., Alan R. Liss, Inc. New York (1983) Sugi, et al., The Use of Fluosol-DA (FDA) in Emergency Situations: A report of 67 clinical cases, Abstract/451.
Atkinson, T.P. et al., "Ion transport mediated by copolymers composed of polyoxyethylene and polyoxypropylene," pp. C20-C26 (1988).
Benner, K. U., et al., "Uber die Wirkung von Pluronic.RTM. F-68, einem Poloxypropylen-Polyoxyyyathylen-Kondensat, auf die ADP-induzierte Thrombocytenaggregation in vitro", Plugers Arch., vol. 315, pp. 45-52 (1970).
Benner, K.U., et al., "Cold-Induced Platelet Aggregation In Vivo And Its Inhibition By A Nonionic Surface Active Substance", Thrombosis Research, vol. 2, pp. 331-342 (1973).
Block and Graft Copolymerization, vol. 2, (ed. by R. J. Ceresa, John Wiley & Sons, 1976), "The Applications of Block Copolymer Polyol Surfactants", L. G. Lundsted and I. R. Schmolka; pp. 174-205 and pp. 255-272 (references).
Block, N. L., et al., "Acutely Traumatized Canine Ureter: Effects of Low Molecular Weight Dextran and Surfactant Pluronic F-68", Urology, vol. III 190-194 (1974).
Byars, N.E., et al. "Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity," Vaccine, vol. 5, pp. 223-228 (Sep. 1987).
Connaghan et al., "Specific Identification of Fibrin Polymers, Fibrinogen Degradation Products and Crosslinked Fibrin Degradation Products in Plasma and Serum with a New Sensitive Technique," Blood, vol. 65, No. 3, pp. 589-597 (Mar. 1985).
Danielson, G., et al., "Use of Pluronic F-68 to Dimish Fat Emboli and Hemolysis During Cardiopulmonary Bypass", The Journal of Thoracic and Cardiovascular Surgery, vol. 59(2), pp. 178-184 (Feb. 1970).
Forman, M. B., et al., "Beneficial Long-Term Effect of Intracoronary Perfluorochemical on Infarct Size and Ventricular Function in a Canine Reperfusion Model", J. Am. Col. of Cardiol., 1082-1080 (May, 1987).
Forman, M. B., et al., "Reduction of Infarct Size with Intracoronary Perfluorochemical in a Canine Preparation of Reperfusion", Circulation, vol. 71, pp. 1060-1068 (1985).
Gaehtgens, P., et al., "Disaggregation of Human Red Blood Cells by Various Surface-Active Agents as Related to Changes of Cell Shape and Hemolysis", Act Heamat., vol. 33, pp. 82-89 (1975).
Goodman, R. L., et al., "Perfluorocarbon Emulsions in Canter Therapy: Preliminary Observations on Presently Available Formulations", Int. J. Radiation Oncology Biol. Phys., vol. 10, pp. 1421-1424 (1984).
Grover, F.L., et al., "Beneficial Effect of Pluronic F-68 on the Microcirculation in Expiramental Hemmorrhagic Schock", Surgical Forum, vol. 21, pp. 30-32 (1970).
Grover, F.L., et al., "A nonionic Surfactant And Blood Viscosity", Arch. Surg., vol. 106, pp. 307-310 (1973).
Grover, F.L., et al., "The Effect of Pluronic.RTM. F-68 On Circulatory Dynamics And Renal and Carotid Artery Flow During Hemorrhagic Shock", Journal of Surgical Research, vol. 17, pp.30-35 (1974).
Harjula, A., et al., "Perfluorocarbon Solution as a Myocardial Preservative", J. Applied Cardiology, vol. 2, pp. 121-136 (1987).
Heron, M. W., et al., "A Method for Measuring a Nonionic Surface-Active Agent (Pluronic F-68) in Biological Fluids", Analytical Biochemistry, vol. 24, pp. 491-495 (1968).
Hoie, J., et al., "Effects of Pluronic.RTM. F-68, Poloralkol, On Vascular Resistance in Vivo", Journal of Surgical Research, vol. 11, pp. 515-517 (1971).
Hunter et al, "The Adjuvant Activity of Nonionic Block Polymer Surfactants I. The Role of Hydrophile-Lipophile Balance," i J. of Immunology, vol. 127, No. 3, pp. 1244-1250 (1981).
Hunter, R.L., "The Adjuvant Activity of Nonionic Block Polymer Surfactants II. Antibody Formluatin and Infammation Related to the Structure of Triblock and Octablock Coploymers," J. Immun., vol. 133, No. 6, pp. 3167-3175 (1984).
Hunter R.L. et al., "The Adjuvant Activity of Nonionic Block Polymer Surfactants. III. Characterization of Selected Biologically Active Surfaces," Scand. J. Immunol., vol. 23, pp. 287-300 (1986).
Hunter R. L. et al., "Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody," Vaccine, vol. 9, pp. 250-256 (Apr. 1991).
Hunter, R.L. et al., "Nonionic Block Coploymer Surfactants as Immunological Adjuvants: Mecanisms of Action and Novel Formulations," Immunological Adjuvants and Vaccines, ed. by Gregoriadis, G. et al., Plenum Publishing Corp., pp. 133-144 (1989).
Hunter et al., "Increased Whole Blood Viscosity during Coronary Bypass Surgery," Thromb. Haemost., vol. 63, No. 1, pp. 6-12 (Feb. 19, 1990).
Hymes, A. C., et al., "Influence of an Industrial Surfactant (Pluronic F-68) on Human Amniotic Fluid Embolism", Amerian Journal Obstetrics and Gynecology, vol. 107(8), pp. 1217-1222 (Aug. 15, 1970).
Hymes, A.C., et al., "The Influence Of An Industrial Surfactant Pluronic.RTM. F-68, In The Treatment of Hemorrhagic Shock", Journal of Surgical Research, vol. 11, pp. 191-197 (1971).
Janoff, A. S., et al., "The Modification of Human Erythrocyte Membrane Structure by Membrane Stabilizers: An Electron Spin Resonance Study", American Journal of Hematology, vol. 10, pp. 171-179 (1981).
Justice, C., et al., "Prevention of Thrombosis With Agents Which Reduce Platelets Adhesiveness", The American Surgeon, vol. 40, pp. 186-189 (Mar. 1974).
Kanter, K. R., et al., "Superiority of Perfluorocarbon Cardio
Culbreth Paula H.
Emanuele R. Martin
Hunter Robert L.
Cytrx Corporation
Shaver Paul F.
LandOfFree
Polyoxypropylene/polyoxyethylene copolymers with improved biolog does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyoxypropylene/polyoxyethylene copolymers with improved biolog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyoxypropylene/polyoxyethylene copolymers with improved biolog will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1609264